Federated Hermes’s Ventyx Biosciences VTYX Stock Holding History

Federated Hermes’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-748	Closed	-$6.75K	–	2173
2025 Q4	$6.75K	Sell	748 -3,948	-84%	-$29.5K	﹤0.01%	1868
2025 Q3	$14.6K	Sell	4,696 -2,774	-37%	-$7.35K	﹤0.01%	1844
2025 Q2	$16K	Sell	7,470 -2,025	-21%	-$3.27K	﹤0.01%	1745
2025 Q1	$10.9K	Buy	+9,495	New	+$16.3K	﹤0.01%	1796
2024 Q4	–	Sell	-7,247	Closed	-$15.8K	–	2198
2024 Q3	$15.8K	Buy	+7,247	New	+$16.7K	﹤0.01%	1768
2024 Q1	–	Sell	-20,407	Closed	-$50.4K	–	2140
2023 Q4	$50.4K	Buy	+20,407	New	+$194K	﹤0.01%	1646

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Federated Hermes's VTYX Position: Q1 2026 in Review

Federated Hermes sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 748 shares — an estimated $6.75K sold.

Federated Hermes first reported a position in VTYX in Q4 2023 and held it in 6 quarters. The position peaked at $50.4K in Q4 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Federated Hermes reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Federated Hermes sold 748 Ventyx Biosciences shares in Q1 2026, an estimated $6.75K.
Federated Hermes first reported a position in Ventyx Biosciences in Q4 2023 and held it in 6 quarters.
Federated Hermes's Ventyx Biosciences position peaked at $50.4K in Q4 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.